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There has been a drastic increase in cesarean delivery rates in
the United States over the past 40 years, such that 32% of all
deliveries were via cesarean in 2015, compared with 5% in
1970.1–3 Cesarean deliveries are associated with increased
morbidity and mortality as well as risks for future pregnan-
cies including uterine rupture, abnormal placentation, and
increased risks during subsequent abdominal surgeries. The
risk of placenta accreta or previa, surgical injury (cystotomy,
bowel injury, ureteral injury), ileus, intensive care unit (ICU)
admission, hysterectomy, and blood transfusion requiring
four or more units has been shown to be significantly
increased with increasing number of cesarean deliveries.4
To avoid these increased risks, women who have had a prior
C-section may opt for a trial of labor after cesarean (TOLAC)
versus a repeat C-section.
Womenwho elect for TOLACmay need operative interven-
tion during the second stage of labor. Indications for operative
intervention occur in 14% of women in the second stage of
labor. The most common indication for intervention is non-
reassuring fetal status followed by prolonged second stage.5
Options to terminate the second stage of labor include repeat
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Abstract Objective To compare outcomes of operative intervention in the second stage of
labor during trial of labor after cesarean (TOLAC).
Study Design A secondary analysis of the Maternal-Fetal Medicine Units Network
cesarean section registry was conducted. Analysis was by first attemptedmode of delivery.
Results A total of 1,837 met inclusion criteria. Subjects in the operative vaginal
groups (OVDs) weremore likely to have a prior vaginal delivery (vacuum 34.2%; forceps
34.3%) than the repeat cesarean delivery (RCD) group (22.6%; p < 0.0001). Most OVD
attempts were successful (forceps 90.4%; vacuum 92.6%). Neonatal morbidity was not
different (12.1% forceps vs. 14.6% vacuum; 14.8% RCD). Maternal morbidity was
highest among forceps deliveries (32.3 vs. 24.3% vacuum; 22.0% RCD, p ¼ 0.0001).
RCD was associated with surgical injury (2.7 vs. 0.7% forceps; 0% vacuum; p < 0.0001),
endometritis (8.4 vs. 3.2% forceps, 1.2% vacuum; p < 0.0001), and wound complica-
tions (1.9 vs. 0.4% forceps; 0.3% vacuum; p ¼ 0.006). OVD was associated with anal
sphincter laceration (22.7% forceps, 15.5% vacuum; 0% RCD; p ¼ 0.01).
Conclusion The success rate of OVD is high in TOLAC with similar outcomes to RCD.
Maternal composite outcomes were highest with forceps-assisted vaginal deliveries.
However, considering overall morbidity, OVD in the second stage of labor in TOLAC is a
reasonable, safe option in selected cases.
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cesarean delivery (RCD)or instrumental deliverywithvacuum
or forceps (operative vaginal delivery). Operative vaginal
delivery is one way in which a cesarean delivery can be
avoided. However, operative vaginal deliveries have declined
since 1990 from 9.01 to 3.30% in 2013.6 This decline is likely
multifactorial but mostly due to decreased training in resi-
dency. There have been a few studies looking at delivery
options during the second stage of labor but little data
specifically on the TOLAC population.
A recent study examined term pregnancies with no prior
vaginal delivery and compared outcomes in vacuum-assisted
deliveries, forceps-assisted deliveries, and cesarean deliv-
eries.7 They found that attempt at vacuum delivery was
associated with the lowest frequency of maternal complica-
tions except for severe lacerations which was lowest in the
cesarean delivery group. Forceps and vacuumdeliverieswere
associated with fewer postpartum infections.7
The goal of this study is to determine the best route of
delivery in the second stage of TOLAC by comparingmaternal
and neonatal outcomes associated with cesarean, vaginal
forceps, and vaginal vacuum deliveries based on the first
attempted mode of delivery.
Study Design
Institutional Review Board exemption for secondary analysis
of existing data was obtained. Data were collected from the
Maternal-Fetal Medicine Units (MFMU) Network cesarean
section registry. The MFMU registry includes women who
had a pregnancy at 20 weeks or more of gestation or whose
infant weighed at least 500 g. Data were prospectively
collected between 1996 and 2002 from 19 academic medical
centers. Data were extracted directly from medical records
by trained study nurses. Neonatal data were collected up to
120 days following delivery or at the time of hospital
discharge.8
A cohort from this database was made which included
women with gestational age more than 37 weeks, singleton
pregnancy, estimated fetal weight more than 2,500 g, and
history of one prior cesarean delivery. Patientswere included
only if they achieved complete cervical dilation. Patients
undergoing planned elective RCD were excluded as well as
patients with multiple prior cesarean (>1). Stillbirths, major
fetal anomalies, noncephalic presentation, mid- or high
forceps, patients with sequential vacuum–forceps or high
forceps were also excluded.7 Fetal station at the time of
intervention was not available through this database
(see ►Fig. 1).
Maternal and neonatal outcomes were compared in this
cohort of women with one prior cesarean between first
attempted mode of delivery in the second stage (vacuum,
forceps, or repeat cesarean). Differences in the frequency
distributions of baseline covariates of women with prior
cesarean delivery undergoing operative intervention in
the second stage of labor were compared via chi-square
test or Fisher’s exact test for categorical variables and t-
test for continuous variables. There were two composite end
points: maternal composite morbidity and neonatal compo-
site morbidity. The maternal composite morbidity includes
uterine rupture/dehiscence, surgical injury (enterotomy,
cystotomy, other), death, endometritis, transfusion, hyster-
ectomy, thromboembolism, wound complication, and anal
sphincter lacerations. Also, neonatal composite morbidity
included neonatal ICU (NICU) admission, hypoxic-ischemic
encephalopathy (HIE), sepsis, Apgar <4 at 5 minutes, peri-
natal death, and birth injury. These composite end points
were compared among the three groups of vacuum, forceps,
and repeat C-section methods of delivery using chi-square
statistics. We report the success rates for each of these
groups and analyses are interpreted in terms of odds ratios.
All analyseswere done at theα significance level of 0.05. Data
analysis was performed using Stata Statistical Software:
Release 14 (StataCorp LP; College Station, TX).
Results
There were a total of 73,257 deliveries over the study period
in the cesarean section registry. Of these, 1,837 had an
operative delivery after reaching the second stage of labor
and thuswere included in our study. Therewere 608 patients
undergoing vacuum attempts, 743 forceps attempts, and 486
RCDs in the second stage of labor (►Fig. 1).
Baseline characteristics between operative vaginal deliv-
eries (vacuum and forceps) and RCD were similar, with no
significant difference between the groups in terms of obesity,
diabetes, chronic hypertension, and pre-eclampsia. The aver-
age age of the patient was 29 years. The overall mean
gestational age at delivery was 395/7 weeks (39.7)
(►Table 1). However, subjects undergoing forceps deliveries
were more likely to be non-Hispanic black or Hispanic.
Additionally, subjects in the operative vaginal delivery
groups were more likely to have had one or more prior
vaginal delivery (vacuum 34.2%, n ¼ 208; forceps 34.3%,
n ¼ 255) than the RCD group (22.6%, n ¼ 110; p < 0.0001).
Most operative vaginal deliveries were successful (forceps
90.4%, n ¼ 672; vacuum 92.6%, n ¼ 563).
Maternal composite morbidity was highest among for-
ceps deliveries (32.3%, n ¼ 240 vs. 24.3%, n ¼ 148 vacuum;
22.0%, n ¼ 107 RCD, p ¼ 0.0001). Cesarean delivery was
associated with a higher incidence of surgical injury (2.7%,
n ¼ 13 vs. 0.7%, n ¼ 5 forceps; 0%, n ¼ 0 vacuum;
p < 0.0001), endometritis (8.4%, n ¼ 41 vs. 3.2%, n ¼ 24
forceps, 1.2%, n ¼ 7 vacuum; p < 0.0001), and wound com-
plications (1.9%, n ¼ 9 vs. 0.4%, n ¼ 3 forceps; 0.3%, n ¼ 2
vacuum; p ¼ 0.006). Forceps deliverywas associatedwith an
increased risk of blood transfusion (3.4%, n ¼ 25 vs. 1.3%,
n ¼ 8 vacuum; 1.9%, n ¼ 9 RCD; p ¼ 0.03). Operative vaginal
delivery was associated with an increased risk of anal
sphincter laceration (22.7%, n ¼ 169 forceps, 15.5%, n ¼ 94
vacuum; 0%, n ¼ 0 RCD; p ¼ 0.01) (►Table 2).
Neonatal composite morbidity was not different among
groups (12.1%, n ¼ 90 forceps vs. 14.6%, n ¼ 89 vacuum;
14.8%, n ¼ 72 RCD). There was no difference in NICU admis-
sions (11.2%, n ¼ 68 vacuum vs. 8.1%, n ¼ 60 forceps; 11.9%
n ¼ 58 RCD, p ¼ 0.0.322), HIE (0.2%, n ¼ 1 vacuum vs. 0.3%,
n ¼ 2 forceps; 0.4% n ¼ 2 RCD, p ¼ 0.0.738), Apgar <4 at
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5 minutes (0.5%, n ¼ 3 vacuum vs. 0.8%, n ¼ 6 forceps; 0.4%,
n ¼ 2 RCD, p ¼ 0.738), perinatal death (0%, n ¼ 0 vacuum vs.
0.1%, n ¼ 1 forceps; 0%, n ¼ 0 RCD, p ¼ 0.0.478), birth injury
(2.8%, n ¼ 17 vacuum vs. 2.8%, n ¼ 21 forceps; 2.3%, n ¼ 11
RCD, p ¼ 0.0.812) (►Table 3).
Conclusion
In our analysis, the success rate of operative vaginal delivery
in the setting of TOLAC is high with similar neonatal and
maternal outcomes to second-stage RCD suggesting this is a
safe option. Operative vaginal delivery was associated with a
lower incidence of surgical injury, wound complications,
uterine rupture, and endometritis but with a higher inci-
dence of anal sphincter laceration. Maternal composite
morbidity was highest among forceps deliveries, with an
increased risk of blood transfusion. There was no difference
in the composite neonatal outcomes.
Our findings are consistent with a recent study by Son
et al9 demonstrating no increased maternal or neonatal
adverse outcomes with operative vaginal delivery compared
with second-stage RCDbutwith decreased endometritis risk.
Our study was able to include a larger sample in the analysis
(600 more women) as we included all women achieving
complete dilation who did not have a mid-forceps delivery
(the prior study was limited to women achieving a docu-
mented þ2 station).
This analysis is strong because of its large cohort size,
multicenter nature, and prespecified, clinically relevant out-
comes. Additionally, analysis was by first attempted mode of
delivery, essentially an intention to treat, which decreases
potential bias.
There are multiple limitations to this study including the
retrospective nature, though a randomized controlled trial is
highly unlikely to be undertaken. The study is also limited by
selection bias as somewomenmay have been poor candidates
for operative vaginal delivery in general or for a certain type of
operative vaginal delivery. The experience level of theprovider
is not known and regional differences among types of opera-
tive vaginal delivery offered cannot be accounted for. Similarly,
Fig. 1 Flow diagram for patient selection.
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some providers who offer both vacuum and forceps deliveries
will offer a forceps delivery if the anticipated delivery will be
more difficult due to maternal effort, station, or fetal position,
and this is not accounted for in our analysis. This likely
contributes to the increased maternal composite morbidity
seenwith forcepsdeliveries. Additionally,weexcludedwomen
withknownmid-forcepsdeliveriesbutdidnotexcludewomen
without a charted fetal station so likely some mid-station
operative vaginal deliveries were included. While these deliv-
eries are no longer recommended due to maternal and fetal
adverse outcomes, they did occur during the time of data
collection and could falsely elevate the incidence of adverse
maternal outcomes in our cohort. Documentation of fetal
station was only recorded at the time of admission, epidural
placement, and maximal cervical dilation. Fetal station was
not recorded at the time of cesarean delivery, and, without
these data, we are unable to determine if these patients
achieved a station where operative vaginal delivery would
evenhavebeen a consideration. Finally, somematernal risks of
RCD cannot be accounted for with this study but should be










29.5 (0.24) 29.0 (0.21) 29.9 (0.25) 0.247
Race
Non-Hispanic 306 (36.1) 334 (39.4) 208 (24.5) 0.003
Non-Hispanic black 146 (31.3) 207 (44.4) 113 (24.3)
Hispanic 108 (27.1) 158 (39.7) 132 (33.2)
Other 48 (38.4) 44 (35.2) 33 (26.4)




34.11 (0.43) 34.97 (0.53) 34.99 (0.54) 0.258
Diabetes 22 (3.6) 28 (3.7) 30 (6.2) 0.072
CHTN 7 (1.2) 7 (1.0) 2 (0.4) 0.410
Pre-eclampsia 20(3.3) 22 (3.0) 23 (4.7) 0.435
Gestational age
Mean (SD)
39.6 (0.046) 39.6 (0.042) 39.8 (0.052) 0.140
Abbreviations: BMI, body mass index; CHTN, chronic hypertension; RCS, repeat cesarean section; SD, standard deviation.
Note: Reference group is RCS.








Maternal composite morbidity 148 (24.3) 240 (32.3) 107 (22.0) <0.0001
Uterine rupture 5 (0.8) 8 (1.1) 19 (3.9) <0.0001
Surgical injury 0 (0) 5 (0.7) 13 (2.7) <0.0001
Cystotomy 0 (0) 4 (0.54) 12 (2.5) <0.0001
Enterotomy 0 (0) 0 (0) 0 (0) NA
Ureter injury 0 (0) 1 (0.13) 1 (0.2) 0.569
Endometritis 7 (1.2) 24 (3.2) 41 (8.4) <0.0001
Transfusion 8 (1.3) 25 (3.4) 9 (1.0) 0.033
Peripartum hysterectomy 2 (0.3) 0 (0) 1 (0.2) 0.318
Venous thromboembolism 3 (0.5) 1 (0.13) 2 (0.4) 0.171
Wound complication 2 (0.3) 3 (0.4) 9 (1.9) 0.006
Anal sphincter laceration 94 (15.5) 169 (22.7) 0 (0) 0.012
Maternal death 0 (0) 0 (0) 0 (0) NA
Abbreviations: NA, not available; RCS, repeat cesarean section.
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considered such as maternal perceptions of failure and poor
birth experience after laboring and needing a cesarean,
increased risk of abnormal placentation in future pregnancies,
increased degree of difficulty in future abdominal surgeries,
and possible limitation on a woman’s family size if she con-
siders risks of future cesareans in this decision.
Operative vaginal deliveries were offered to significantly
higher number of women with prior vaginal deliveries. This
likely reflects the provider’s preference to offer operative
vaginal deliveries to those women who are at increased
likelihood of having a successful vaginal delivery. Women
who have had prior vaginal births have increased success
rates of future vaginal deliveries. Choosing appropriate
patients for an operative vaginal delivery is likely why the
success rate of operative vaginal deliveries is high in this
study. An opportunity for future studies could look at out-
comes and success rates of women with and without prior
vaginal deliveries.
Our analysis highlights the inherent risks of each type of
operative delivery in the second stage. As is seen with all
women undergoing operative intervention in the second
stage, some risks are higher for operative vaginal delivery
(e.g., perineal lacerations) and some are higher in the cesar-
ean delivery group (e.g., surgical injury or wound complica-
tion); these risks are still present among women undergoing
TOLAC with similar rates. As the neonatal outcomes are not
significantly different, operative vaginal delivery andRCDare
viable options in patients undergoing a TOLAC and the risks
of each should be discussed with the patient to allow for
shared decision making.
A great emphasis has been placed by governing bodies
(American College of Obstetricians and Gynecologists–
Society for Maternal-Fetal Medicine) to avoid the first cesar-
ean section including redefinition of basic concepts such as
active labor. This study supports that initiative one step later
and places special attention in trying to prevent the second
cesarean. Maternal morbidity only increases with repetitive
cesarean sections, to this end, we believe that every effort
made to avoid the second cesarean should be done, starting
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Neonatal composite morbidity 89 (14.6) 90 (12.1) 72 (14.8) 0.29
NICU admission 68 (11.2) 60 (8.1) 58 (11.9) 0.322
HIE 1 (0.2) 2 (0.3) 2 (0.4) 0.738
Apgar <4 at 5 min 3 (0.5) 6 (0.8) 1 (0.2) 0.402
Perinatal death 0 (0) 1 (0.1) 0 (0) 0.478
Birth injury 17 (2.8) 21 (2.8) 11 (2.3) 0.812
Abbreviations: HIE, hypoxic-ischemic encephalopathy; NICU, neonatal intensive care unit; RCS, repeat cesarean section.
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